In recent months, the Food and Drug Administration has taken some actions regarding JUUL, including issuing warning letters to retailers for selling the product to minors. The FDA also asked the maker, JUUL Labs, to turn over documents related to marketing, health effects and use among youth. While these actions are encouraging, problems with tobacco products like JUUL won’t be addressed until the FDA fully regulates e-cigarettes and establishes a strong pre-market review process to prevent these kinds of products from being sold in the first place.
Truth Initiative and five other public health and medical groups called on the FDA to take action on JUUL in April. The groups specified five actions, including removing certain JUUL flavors, suspending internet sales and prohibiting branded merchandise.